Changes Connected to Early Chronic Pancreatitis and Early Pancreatic Cancer in Endoscopic Ultrasonography (EUS): Clinical Implications

被引:0
作者
Pawelec, Natalia [1 ]
Durko, Lukasz [1 ]
Malecka-Wojciesko, Ewa [1 ]
机构
[1] Med Univ Lodz, Dept Digest Tract Dis, PL-90153 Lodz, Poland
关键词
ECP; early PDAC; EUS; FINE-NEEDLE-ASPIRATION; ULTRASOUND ELASTOGRAPHY; DIFFERENTIAL-DIAGNOSIS; DIABETES-MELLITUS; TUMOR SIZE; FOLLOW-UP; LESIONS; ACCURACY; SURVIVAL; EXOCRINE;
D O I
10.3390/cancers17111891
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chronic pancreatitis (CP) is a progressive condition that is associated with severe complications. Diagnosis of late CP is easy due to characteristic clinical presentation and pathognomonic imaging findings, such as pancreatic calcifications. Early changes, such as lobularity and a dilated main pancreatic duct, are very subtle and challenging to detect with ultrasonography (US) or even computed tomography (CT). Data were accumulating on the usefulness of EUS in the early diagnosis of CP. The sensitivity values for detecting early CP (ECP) by US, MRI, and EUS were 67-69%, 77-78%, and 81-84%, respectively. The specificity values for detecting ECP by US, MRI, and EUS were 90-98%, 83-96%, and 90-100%, respectively. Pancreatic cancer (PDAC) is one of the leading cancers worldwide, with increasing morbidity. Due to its poor prognosis and survival, early diagnosis is crucial. For this indication, EUS also shows better outcomes compared to other imaging methods, especially in tumors < 2 cm. The sensitivity and specificity for diagnosing PDAC with MRI and EUS were 52.3-93%, 77.1-89%, 72-100%, and 90%, respectively. In addition, EUS can detect precancerous conditions that are associated with a higher risk of PDAC. EUS-assisted new techniques, like elastography and contrast enhancement, facilitate the diagnosis of pancreatic lesions and make it even more accurate. Early PDAC changes, such as main pancreatic duct dilatation or irregular margins of pancreatic solid masses, may be detected with EUS. This review describes the efficacy of different imaging techniques in the early detection of CP and PDAC. In addition, we describe the useful interventions made possible by early diagnosis of PDAC and CP.
引用
收藏
页数:26
相关论文
共 123 条
[1]   Prevalence of Diabetes Mellitus in Pancreatic Cancer Compared to Common Cancers [J].
Aggarwal, Gaurav ;
Kamada, Pratima ;
Chari, Suresh T. .
PANCREAS, 2013, 42 (02) :198-201
[2]   EUS-FNA and ROSE in solid lesions of the pancreas; have the same diagnostic efficacy compared to pancreatic sites? [J].
Ak, Cagatay ;
Sayar, Suleyman ;
Kilic, Ebru Tarikci ;
Kahraman, Resul ;
Ozturk, Oguzhan ;
Zemheri, Itir Ebru ;
Ozdil, Kamil .
NORTHERN CLINICS OF ISTANBUL, 2022, 9 (05) :464-469
[3]   Volanesorsen to Prevent Acute Pancreatitis in Hypertriglyceridemia [J].
Alexander, Veronica J. ;
Karwatowska-Prokopczuk, Ewa ;
Prohaska, Thomas A. ;
Li, Lu ;
Geary, Richard S. ;
Gouni-Berthold, Ioanna ;
Oral, Elif A. ;
Hegele, Robert A. ;
Stroes, Erik S. G. ;
Witztum, Joseph L. ;
Tsimikas, Sotirios .
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (05) :476-477
[4]   Diagnosing Chronic Pancreatitis [J].
Anaizi, Ahmad ;
Hart, Phil A. ;
Conwell, Darwin L. .
DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (07) :1713-1720
[5]   Mechanisms of pancreatic fibrosis [J].
Apte, MV ;
Wilson, JS .
DIGESTIVE DISEASES, 2004, 22 (03) :273-279
[6]  
ARIYAMA J, 1990, INT J PANCREATOL, V7, P37
[7]  
Barry K, 2018, AM FAM PHYSICIAN, V97, P385
[8]   Imaging of inflammatory disease of the pancreas [J].
Bastati, Nina ;
Kristic, Antonia ;
Poetter-Lang, Sarah ;
Messner, Alina ;
Herold, Alexander ;
Hodge, Jacqueline C. ;
Schindl, Martin ;
Ba-Ssalamah, Ahmed .
BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1123)
[9]   Plectin-1 as a Novel Biomarker for Pancreatic Cancer [J].
Bausch, Dirk ;
Thomas, Stephanie ;
Mino-Kenudson, Mari ;
Fernandez-del Castillo, Carlos ;
Bauer, Todd W. ;
Williams, Mark ;
Warshaw, Andrew L. ;
Thayer, Sarah P. ;
Kelly, Kimberly A. .
CLINICAL CANCER RESEARCH, 2011, 17 (02) :302-309
[10]  
Beyer G, 2020, LANCET, V396, P499, DOI 10.1016/S0140-6736(20)31318-0